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Inferior vena cava and coronary sinus obstruction after percutaneous
atrial septal defect device closure requiring surgical revision
Alan Weng Siong Soo, MB, MRCSI, David G. Healy, MB, MRCSI, Kevin Walsh, FRCP, and Freddie Wood, FRCSI,
Dublin, Ireland
Percutaneous device closure for atrial septal defects hasbeen gaining in popularity as a treatment modality ofatrial septal defects because of the good medium-termresults and lower complication rate compared with open
surgical closure. There are few reported complications arising
from atrial septal defect device closure. Reported complications
have been limited to device embolization, thrombus formation,
cardiac arrhythmia, and delivery system failures.
Case Summary
We present a 59-year-old woman with a history of decreasing
exercise tolerance and deteriorating exertional dyspnea. A systolic
murmur was noted on examination, which on further study with
echocardiography was identified as a large (2.4 cm) septum se-
cundum atrial septal defect. Right- and left-sided heart catheter-
ization revealed a left-to-right shunt of 3.7:1 and normal coronary
arteries. The atrial septal defect was closed with a 40-mm trans-
catheter atrial septal defect occlusion device: the Amplatzer Septal
Occluder system (AGA Medical Corporation, Golden Valley,
Minn). The patient was discharged the next day.
Three weeks after the primary procedure, the patient was re-
admitted to the hospital with reports of exertional dyspnea, left-
sided chest pain radiating down the left arm, and presyncope
episodes. On examination, she was found to be hypotensive. Elec-
trocardiogram showed new-onset, widespread T-wave inversion.
Transthoracic echocardiography showed the device to have com-
pletely occluded the atrial septal defect. However, some turbulent
flow was shown in the inferior vena cava, which indicated inferior
vena cava stenosis. Catheterization confirmed intermittent inferior
vena cava stenosis. Ultrasound and computed tomography of the
abdomen were performed. Both investigations revealed that the
inferior vena cava was of normal caliber and that there was no
evidence of obstruction in the intra-abdominal or intrathoracic
inferior vena cava. An attempt at dilating the inferior vena cava
was performed with catheterization. This made no improvement,
and the patient’s condition deteriorated.
Surgical exploration was advised. At operation the inferior rim
of the device was seen clearly, partially occluding the inferior vena
cava and coronary sinus (Figure 1).
The device was then removed (Figure 2), leaving a large
septum secundum atrial septal defect that was closed using a
pericardial patch. The patient’s postoperative care was uneventful,
and her symptoms resolved completely. She remains symptom-
free at the 3-month follow-up.
Comment
Traditionally, atrial septal defect has been repaired surgically with
good long-term results.1 However, with the advent of the Am-
platzer Septal Occluder device, secundum atrial septal defect is
increasingly being repaired percutaneously with such a device.
Repairing atrial septal defect percutaneously has proved to be safe
and effective, and has good-medium term results in a pediatric
population. Experience is limited in adults, although early evi-
dence shows the procedure to be safe and effective.2 In comparison
with surgical repair, percutaneous closure of atrial septal defect has
a comparable success rate, lower morbidity, and reduced hospital
stay in the short term. Long-term results are awaited.3 However,
complications such as device malposition, residual shunts, hemo-
lysis, embolization of device, partial occlusion of superior vena
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Figure 1. Impression by author showing position of low septum
secundum atrial septal defect and position of device.
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cava, damage to mitral or tricuspid valves, cardiac perforation, and
thrombus formation have all been reported.4 These complications
usually require open surgical repair, although there is an increasing
trend to retrieve the embolized device percutaneously.5
Devices such as the Amplatzer Septal Occluder system are
still undergoing postmarket surveillance. The role of these
devices is increasingly being expanded. Newer roles include
closure of aorto-atrial fistulas and ruptured sinus of Valsalva
aneurysm. Because the role of these devices is frequently being
reevaluated, both the interventional cardiologist and cardiotho-
racic surgeon who work in units where these devices are being
used should be aware of the potential complications and man-
agement.
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Figure 2. Explanted Amplatzer Septal Oc-
cluder system (AGA Medical Corporation,
Golden Valley, Minn).
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